Literature DB >> 33866544

Regression with interval-censored covariates: Application to cross-sectional incidence estimation.

Doug Morrison1, Oliver Laeyendecker2,3, Ron Brookmeyer1.   

Abstract

A method for generalized linear regression with interval-censored covariates is described, extending previous approaches. A scenario is considered in which an interval-censored covariate of interest is defined as a function of other variables. Instead of directly modeling the distribution of the interval-censored covariate of interest, the distributions of the variables which determine that covariate are modeled, and the distribution of the covariate of interest is inferred indirectly. This approach leads to an estimation procedure using the Expectation-Maximization (EM) algorithm. The performance of this approach is compared to two alternative approaches, one in which the censoring interval midpoints are used as estimates of the censored covariate values, and another in which the censored values are multiply imputed using uniform distributions over the censoring intervals. A simulation framework is constructed to assess these methods' accuracies across a range of scenarios. The proposed approach is found to have less bias than midpoint analysis and uniform imputation, at the cost of small increases in standard error.
© 2021 The International Biometric Society.

Entities:  

Keywords:  EM algorithm; HIV/AIDS; cross-sectional incidence estimation; interval-censored covariates; joint modeling

Mesh:

Year:  2021        PMID: 33866544      PMCID: PMC9363237          DOI: 10.1111/biom.13472

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   1.701


  16 in total

1.  On the statistical accuracy of biomarker assays for HIV incidence.

Authors:  Ron Brookmeyer
Journal:  J Acquir Immune Defic Syndr       Date:  2010-08       Impact factor: 3.731

Review 2.  Beyond detuning: 10 years of progress and new challenges in the development and application of assays for HIV incidence estimation.

Authors:  Michael P Busch; Christopher D Pilcher; Timothy D Mastro; John Kaldor; Gaby Vercauteren; William Rodriguez; Christine Rousseau; Thomas M Rehle; Alex Welte; Megan D Averill; Jesus M Garcia Calleja
Journal:  AIDS       Date:  2010-11-27       Impact factor: 4.177

3.  Hormonal contraceptive use and HIV disease progression among women in Uganda and Zimbabwe.

Authors:  Charles S Morrison; Pai-Lien Chen; Immaculate Nankya; Anne Rinaldi; Barbara Van Der Pol; Yun-Rong Ma; Tsungai Chipato; Roy Mugerwa; Megan Dunbar; Eric Arts; Robert A Salata
Journal:  J Acquir Immune Defic Syndr       Date:  2011-06-01       Impact factor: 3.731

4.  Community viral load, antiretroviral therapy coverage, and HIV incidence in India: a cross-sectional, comparative study.

Authors:  Sunil Suhas Solomon; Shruti H Mehta; Allison M McFall; Aylur K Srikrishnan; Shanmugam Saravanan; Oliver Laeyendecker; Pachamuthu Balakrishnan; David D Celentano; Suniti Solomon; Gregory M Lucas
Journal:  Lancet HIV       Date:  2016-03-11       Impact factor: 12.767

5.  Estimation of current human immunodeficiency virus incidence rates from a cross-sectional survey using early diagnostic tests.

Authors:  R Brookmeyer; T C Quinn
Journal:  Am J Epidemiol       Date:  1995-01-15       Impact factor: 4.897

6.  Use of Hepatitis C Virus (HCV) Immunoglobulin G Antibody Avidity as a Biomarker to Estimate the Population-Level Incidence of HCV Infection.

Authors:  Eshan U Patel; Andrea L Cox; Shruti H Mehta; Denali Boon; Caroline E Mullis; Jacquie Astemborski; William O Osburn; Jeffrey Quinn; Andrew D Redd; Gregory D Kirk; David L Thomas; Thomas C Quinn; Oliver Laeyendecker
Journal:  J Infect Dis       Date:  2016-01-14       Impact factor: 5.226

7.  Estimation of HIV incidence using multiple biomarkers.

Authors:  Ron Brookmeyer; Jacob Konikoff; Oliver Laeyendecker; Susan H Eshleman
Journal:  Am J Epidemiol       Date:  2013-01-09       Impact factor: 4.897

8.  Performance of a limiting-antigen avidity enzyme immunoassay for cross-sectional estimation of HIV incidence in the United States.

Authors:  Jacob Konikoff; Ron Brookmeyer; Andrew F Longosz; Matthew M Cousins; Connie Celum; Susan P Buchbinder; George R Seage; Gregory D Kirk; Richard D Moore; Shruti H Mehta; Joseph B Margolick; Joelle Brown; Kenneth H Mayer; Beryl A Koblin; Jessica E Justman; Sally L Hodder; Thomas C Quinn; Susan H Eshleman; Oliver Laeyendecker
Journal:  PLoS One       Date:  2013-12-27       Impact factor: 3.240

9.  Identification and validation of a multi-assay algorithm for cross-sectional HIV incidence estimation in populations with subtype C infection.

Authors:  Oliver Laeyendecker; Jacob Konikoff; Douglas E Morrison; Ronald Brookmeyer; Jing Wang; Connie Celum; Charles S Morrison; Quarraisha Abdool Karim; Audrey E Pettifor; Susan H Eshleman
Journal:  J Int AIDS Soc       Date:  2018-02       Impact factor: 5.396

10.  A comparison of two biological markers of recent hepatitis C virus (HCV) infection: implications for the monitoring of interventions and strategies to reduce HCV transmission among people who inject drugs.

Authors:  Vivian D Hope; Ross J Harris; Peter Vickerman; Lucy Platt; Justin Shute; Katelyn J Cullen; Samreen Ijaz; Sema Mandal; Fortune Ncube; Monica Desai; John V Parry
Journal:  Euro Surveill       Date:  2018-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.